Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized controlled trial

Abstract Background The benefits of intravenous thrombolysis in patients with acute minor stroke remain controversial. For the aim of providing a better therapeutic strategy, high-quality trials are required to validate the efficacy of thrombolytic medicine other than intravenous recombinant tissue...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	BMC Medicine
المؤلفون الرئيسيون:	Yongli Tao, Yuan Gao, Lu Zhao, Yafang Xu, Chenyang Jiang, Kai Liu, Hui Fang, Lulu Pei, Xin Wang, Rui Zhang, Jun Wu, Jing Yang, Xinsheng Han, Hongling Guo, Baoguo Xue, Jinlou Li, Yuqian Liu, Hongqiu Gu, Kejin Du, Xin Cheng, Qiang Dong, Duolao Wang, Ferdinando S. Buonanno, MingMing Ning, Yuming Xu, Bo Song, the TRUST Trial Investigators
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2025-01-01
الموضوعات:	Minor stroke Intravenous thrombolysis Urokinase Antiplatelet therapy Function outcome
الوصول للمادة أونلاين:	https://doi.org/10.1186/s12916-024-03820-2